Measuring Transparency in the Palestinian Public Pharmaceutical Sector in the Gaza Strip

Musallam, Areej (2015) Measuring Transparency in the Palestinian Public Pharmaceutical Sector in the Gaza Strip. Masters thesis, Al Azhar University Gaza.

[img] Text
Measuring transparency in the Palestinian public pharmaceutical sector in.pdf

Download (5MB)


Medicines constitute an important component of health care systems worldwide. Therefore, inefficiencies in governance of pharmaceutical system negatively affect health outcomes and access to essential medicines particularly in developing countries. The primary objective of the study is to measure the level of transparency and vulnerability to corruption in three functions of the pharmaceutical system (registration, licensing and inspection) in the Gaza Strip (GS). The second objective is to introduce a comparative analysis that highlights the position of the Palestinian pharmaceutical system in the GS compared to some other developing countries who conducted the same assessment. Standardized questionnaires adapted from the World Health Organization (WHO) assessment tool was used in conducting 48 semi-structured interviews with 37 Key Informants (KIs) in the public and private pharmaceutical system. The responses to the questions were rated and then converted to numeral scores. The lower scores suggested greater vulnerability to corruption while the higher scores suggested lower vulnerability. The results showed that the registration process scored 4.83, the licensing of pharmaceutical establishments scored 5.33 and the inspection of pharmaceutical establishments scored 3.68. The average score for the three functions was 4.61. This score is one of the lowest among the compared countries and it means that the pharmaceutical sector in the GS is moderately vulnerable to corruption. The low scores in the three functions can be attributed to a number of lapses in the good governance for medicines mechanisms including the lack of national drug policy; the absence of a basic drug law; a very antiquated drug legislation; fragmentation of drug regulatory functions between different bodies within the Ministry of Health (MOH); lack of adequate financial and human resource; lack of sufficient operational and functional committees responsible for decision making in different functions; lack of standard operating procedures (SOPs) and guidelines for all functions; lack of a conflict of interest policy; lack of independent appeal system; and finally weak law enforcement. In order to ensure transparency and accountability and to promote good governance in the public pharmaceutical sector in the GS, two steps are required: first, legislative and administrative reforms. This include revision and adjustment of existing laws, policies, administrative structures and processes. Second, law enforcement through strong and efficient management systems.

Item Type: Thesis (Masters)
Subjects: Q Science > Q Science (General)
Depositing User: أ. طارق زياد عبد حنونة
Date Deposited: 18 Aug 2020 08:48
Last Modified: 18 Aug 2020 08:48

Actions (login required)

View Item View Item